Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04320888Phase 2Active Not Recruiting
Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial
Hematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more
PrincipalinvestigatorStart date: 2021-05-03

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Giselle Sholler, MD

Beat Childhood Cancer at Atrium Health

Related
10 trials

Shared therapeutic areas:

Refractory NeuroblastomaWilms Tumor
Similarity Score2%

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Recurrent Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Edward A Neuwelt

OHSU Knight Cancer Institute

Related
6 trials

Shared therapeutic areas:

Recurrent Malignant Germ Cell TumorRecurrent Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Amir A Jazaeri

M.D. Anderson Cancer Center

Related
7 trials

Shared therapeutic areas:

Recurrent OsteosarcomaRefractory Osteosarcoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Luhua (Michael) Wang

M.D. Anderson Cancer Center

Related
13 trials

Shared therapeutic areas:

Recurrent Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

AeRang Kim, MD, PhD

Children's National Research Institute

Related
7 trials

Shared therapeutic areas:

Wilms Tumor
Similarity Score1%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Wilms Tumor

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Hematopoietic and Lymphatic System Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

David Hui, MD

M.D. Anderson Cancer Center

Related
13 trials

Shared therapeutic areas:

Recurrent Malignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Bilal Omer, MD

Baylor College of Medicine

Related
7 trials

Shared therapeutic areas:

Refractory Neuroblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04320888Phase 2PrincipalInvestigator

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Hematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more
Active Not Recruiting

All 1 trials loaded